pillbase.ru

ETCAMAH

Active substance: camizestrant

TABLET, FILM COATED · CAMIZESTRANT 75 mg/1

United StatesActive

Marketing holder: AstraZeneca Pharmaceuticals LP

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Etcamah
    camizestrant
    EMEA/H/C/006494
    AstraZeneca AB 
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12099-0edd-7a6d-8729-fff6de686bd2;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0310-0075
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 0310-0075 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0310-0075 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0310-0075 · Verified 2026-10-09 · open in source